| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 99.61× | 99.61× | 101.76× | 116.10× | 101.03× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2.65× | 2.06× | 2.61× | 3.07× | 62.19× | ||
| 0.47× | 0.47× | 0.68× | 0.87× | 1.03× | ||
| 3.17× | 3.17× | 0.84× | 1.26× | 2.53× | ||
| 1.66× | 1.66× | 0.45× | 0.52× | 0.67× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 101.03 | 116.10 | 101.76 | 99.61 | 99.61 | |
| Working Capital Turnover | 62.19 | 3.07 | 2.61 | 2.06 | 2.65 | |
| Asset Turnover | 1.03 | 0.87 | 0.68 | 0.47 | 0.47 | |
| Cash Conversion (CFO/Net Income) | 2.53 | 1.26 | 0.84 | 3.17 | 3.17 | |
| CFO/EBITDA | 0.67 | 0.52 | 0.45 | 1.66 | 1.66 |